M7K-30959-48777
3 vaccinations
3 coded responses
28 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 981 / WA
- Registered
- 2021-01-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-06
Dose 1 — Pfizer-BioNTech
-
2021-01-27
Registered in v-safe
-
2021-01-27
Dose 2 — Pfizer-BioNTech
- 2021-01-27
- 2021-01-28
-
2021-01-29
Survey response — days 1–6 daily, dose 2MedDRA: Rhinorrhoea, Sinus congestion — Feeling: GoodFree text: Runny nose and sinus congestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-30
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-10
- 2021-02-17
- 2021-02-24
- 2021-03-05
- 2021-03-10
- 2021-04-28
- 2021-07-28
-
2022-01-27
Survey response — 12 months, dose 2MedDRA: Abortion spontaneous, Dyspnoea exertional, Hypertension, Pulmonary oedema — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationFree text: Shortness of breath with exertion, pulmonary edema, hypertension, miscarriageMedDRA releases: 2024-11 · check-in free text available
-
2022-01-27
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
-
2022-01-28
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2022-10-08
Dose 3 — Pfizer-BioNTech
-
2022-10-09
Survey response — days 1–6 daily, dose 3MedDRA: Rhinorrhoea — Feeling: Fair · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Runny noseMedDRA releases: 2024-11 · check-in free text available
- 2022-10-10
- 2022-10-11
- 2022-10-13
- 2022-10-14
- 2022-10-17
- 2022-10-24
- 2022-10-29
- 2022-11-07
- 2022-11-13
- 2022-11-19
- 2023-04-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-06 | Pfizer-BioNTech | |
| 2 | 2021-01-27 | Pfizer-BioNTech | |
| 3 | 2022-10-08 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-01-27 | Successful 2022-01-28 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Runny nose and sinus congestion
Release 11 — 12 months, dose 2
Symptoms: Shortness of breath with exertion, pulmonary edema, hypertension, miscarriage
Release 12 — days 1–6 daily, dose 3
Systemic reaction (other): Runny nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | · | · | ✓ |
| SD | Dyspnoea exertional | · | · | ✓ |
| SD | Hypertension | · | · | ✓ |
| SD | Pulmonary oedema | · | · | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
| SRO | Sinus congestion | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release